To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

A new class of lipids improve the rates at which lipid nanoparticles (LNPs) successfully deliver RNA therapeutics and gene editing tools, promising to increase their effectiveness of such treatments.

"Everything injected into the bloodstream is eventually ends up in the liver — that's just how our anatomy works," Professor ...

They are composed of a lipid core stabilized by surfactants or other agents. This lipid core provides a hydrophobic environment ideal for encapsulating genetic materials such as messenger RNA (mRNA) ...

Averna Therapeutics, Inc. ("Averna"; formerly known as Exsilio Therapeutics, Inc.), a biotechnology company developing genomic medicines that insert therapeutic changes into the genome, today ...

Lipid nanoparticles carrying messenger RNA is the technology underpinning coronavirus vaccines. Sahay's team will work on developing novel platforms and formulations capable of encapsulating large ...

a clinical-stage vaccine company, is proud to announce a license to HDT Bio's proprietary self-amplifying replicon RNA (repRNA) and lipid nanoparticle (LION™) technologies for use in malaria ...

DNA-nanoparticle motors are exactly as they sound: tiny artificial motors that use the structures of DNA and RNA to propel motion by enzymatic RNA degradation. Essentially, chemical energy is ...